← Browse by Condition
Medical Condition
chronic myelomonocytic leukemia 1
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT06950034 Phase 1
Recruiting
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Enrollment
105 pts
Location
United States
Sponsor
Solu Therapeutics, Inc
NCT04734990 Phase 1, Phase 2
Recruiting
Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Enrollment
44 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center